Phosphocreatine in cardiac surgery patients: A meta-analysis of randomized controlled trials
Journal of Cardiothoracic and Vascular Anesthesia | Feb 17, 2018
Mingxing F, et al. - Whether phosphocreatine (PCr) would improve heart performance as compared with standard treatment in cardiac surgery, was investigated in this meta-analysis of randomized controlled trials. The analyzed evidence demonstrated that PCr administration was associated with reduced rates of intraoperative inotropic support and major arrhythmias, and increased spontaneous recovery of the cardiac rhythm after aortic declamping.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries